** Shares of Lumibird LBIRD.PA down 3%, paring losses of about 10%, after the French laser maker's annual revenue and core profit outlook failed to capture investors
** Lumibird's 2025 revenues grew over 10% at constant scope and exchange rates to nearly 226 million euros ($268 million)
** However, Portzamparc analyst Jeremy Sallee says "the slowdown in Defense/Space activity in fourth quarter - the main growth driver over the first nine months - along with the lack of a catch-up in the Medical segment, may have led to some disappointment"
** He adds that he believes the market reaction is "exaggerated" given the good outlook for 2025 EBITDA, as well as "very positive" in Medtech division's performance
** Including today's fall, the stock has gained 4.25% YTD.
($1 = 0.8418 euros)
(Reporting by Mateusz Rabiega)
((Mateusz.rabiega@tr.com))